Centre for Evaluation and Methods
Browse by
Recent Submissions
-
Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
(Oxford University Press, 2024-03-24)BACKGROUND AND AIMS: Contrast-induced nephropathy (CIN), also known as contrast-associated acute kidney injury (CA-AKI) underlies a significant proportion of the morbidity and mortality following coronary angiographic ... -
Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
(NIHR Journals Library, 2020-12)Background Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity. Early identification of women at risk is needed to plan management. Objectives To assess the performance of existing ... -
Economic burden of osteoporosis in the world: A systematic review.
(2020)Background: Osteoporosis is a skeletal disease that is associated with a reduction in bone mass and microstructures and deterioration of bone tissue. It is also associated with an increased risk of fracture that is the ... -
Economic evaluation of the utilization of telemedicine for patients with cardiovascular disease: a systematic review.
(2020-11)Cardiovascular disease is one of the major causes of mortality in the world, with high human and financial burdens on communities. Telemedicine is a tool for providing services for patients that are difficult to access or ... -
Private Demand for Covid-19 Vaccine: A Contingent Assessment from a Low-and Middle-income Country.
(Brieflands, 2021)This study aimed to estimate Iranian willingness to pay (WTP) for a hypothetical COVID-19 vaccine and its determinants. A cross-sectional online survey was conducted from May 2nd to 20th, 2020 among the general population ... -
Economic Evaluation of Palliative Care for Patients with Cancer Disease: A Systematic Review.
(Iran University of Medical Sciences, 2022-11-23)Background: With the increase in the population of cancer patients and the importance of reducing the economic burden of disease, it is very important to offer solutions that can provide the services needed by this group ... -
Cost-effectiveness of osimertinib in the treatment of advanced EGFR-mutated non-small cell lung cancer: a systematic review.
(Taylor & Francis, 2021-12-12)BACKGROUND: The most common type of lung cancer is advanced and mutant non-small cell lung cancer (NSCLC). Although targeted tyrosine kinase inhibitors (TKIs) have reconstructed the care of these patients, the resistance ... -
Serum and 24-hour urinary tests cost-effectiveness in stone formers
(BMC, 2023-08-27)Objective To assess the routine serum and 24-hour urine tests proficiency in diagnosing the baseline metabolic abnormality of kidney stone formers. Methods This study analyzes the routine serum and 24-hour urine tests ... -
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening.
(Springer Nature, 2023-11-21)INTRODUCTION: This study investigates Iranian men's willingness to pay (WTP) for prostate cancer (PCa) screening and influencing factor, along with the impact of information. METHOD: We assessed preferences for prostate ... -
A cost-benefit analysis of genetic screening test for breast cancer in Iran.
(BMC, 2024-03-01)BACKGROUND: This study aimed to evaluate the implementation of the population- and family history (FH) -based screening for BReast CAncer (BRCA) in Iran, a country where less than 10% of breast cancer cases are attributable ... -
A cost-benefit analysis of mass prostate cancer screening.
(2024-05-05)BACKGROUND: Prostate cancer (PCa) causes a substantial health and financial burden worldwide, underscoring the need for efficient mass screening approaches. This study attempts to evaluate the Net Cost-Benefit Index (NCBI) ... -
Men's willingness to pay for prostate cancer screening: a systematic review.
(2020-12-09)BACKGROUND: This study aimed to review studies on willingness to pay (WTP) for prostate cancer screening. METHODS: This systematic-review was conducted based on the Preferred Reporting Items for Systematic Reviews guidelines. ... -
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use.
(Nature Research, 2024-05-25)Bacteria are becoming increasingly resistant to antibiotics, reducing our ability to treat infections and threatening to undermine modern health care. Optimising antibiotic use is a key element in tackling the problem. ... -
Exploring the benefits, harms, and costs of genomic newborn screening for rare diseases
(Nature Research, 19-06-2024)